tiprankstipranks
Neurocrine Biosciences (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
RESEARCH TOOLSreports
Want to see NBIX full AI Analyst Report?

Neurocrine (NBIX) Stock News & Sentiment

1,581 Followers
Neurocrine’s New Tardive Dyskinesia Trial Adds Fresh Optionality for NBIX Investors
Premium
Company Announcements
Neurocrine’s New Tardive Dyskinesia Trial Adds Fresh Optionality for NBIX Investors
5d ago
NBIX
Neurocrine Closes Soleno Deal, Expands Rare Disease Portfolio
Premium
Company Announcements
Neurocrine Closes Soleno Deal, Expands Rare Disease Portfolio
6d ago
8K
NBIX
Evan Seigerman Maintains Hold on Neurocrine as Strong Commercial Execution Drives Price Target Increase to $144 Amid Strategic Uncertainty
Premium
Ratings
Evan Seigerman Maintains Hold on Neurocrine as Strong Commercial Execution Drives Price Target Increase to $144 Amid Strategic Uncertainty
18d ago
NBIX
Neurocrine Biosciences: Hold Maintained as Analyst Lifts Price Target to $191 Amid Strong Ingrezza Demand and Pipeline Execution Risks
Premium
Ratings
Neurocrine Biosciences: Hold Maintained as Analyst Lifts Price Target to $191 Amid Strong Ingrezza Demand and Pipeline Execution Risks
18d ago
NBIX
Neurocrine Remains Top Pick on Durable Multi‑Year Growth Outlook; Buy Rating Reiterated with Unchanged $200 Price Target
Premium
Ratings
Neurocrine Remains Top Pick on Durable Multi‑Year Growth Outlook; Buy Rating Reiterated with Unchanged $200 Price Target
19d ago
NBIX
Neurocrine Biosciences Delivers Record Quarter, Eyes 2027
Premium
Company Announcements
Neurocrine Biosciences Delivers Record Quarter, Eyes 2027
19d ago
NBIX
Ami Fadia Reiterates Buy on NBIX After Strong 1Q26 Beat and Robust Ingrezza and Crenessity Demand
Premium
Ratings
Ami Fadia Reiterates Buy on NBIX After Strong 1Q26 Beat and Robust Ingrezza and Crenessity Demand
19d ago
NBIX
More NBIX News >

NBIX News on the Web

Neurocrine initiated with Outperform at Bernstein on long runway of key drugs
TipRanks News
Bullish
Neurocrine initiated with an Outperform at Bernstein
TipRanks News
Bullish
Neurocrine’s New Tardive Dyskinesia Trial Adds Fresh Optionality for NBIX Investors
TipRanks News
Bullish
Neurocrine Unveils New INGREZZA Findings In Mild Tardive Dyskinesia At APA 2026; Closes Soleno Deal
rttnews
Bullish
Neurocrine announces new data from a clinician survey in Ingrezza
TipRanks News
Bullish
Neurocrine Closes Soleno Deal, Expands Rare Disease Portfolio
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Neurocrine completes acquisition of Soleno Therapeutics
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
NBIX
Sector Average
Media Buzz
This Week8 articles
Weekly Average9.75 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
8 articles about NBIX were published this week. In an average week, 9.75 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 9.75 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      99% of articles about NBIX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week